Clinical Trials Sponsored by DepYmed Inc.

Total 35819 results

Northwell Health
DepYmed Inc.

Terminated

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Defymed

Recruiting

Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes (Pilot'Ex)

Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia

France
Depomed

Completed

Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations

Parkinson's Disease | Motor Fluctuations

United States
Depomed

Completed

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

Neuralgia,Postherpetic

United States, Russian Federation, Argentina
Depomed

Completed

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Pain

United States
Depomed

Completed

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

Migraine

United States
Depomed

Completed

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Hot Flashes

United States
Depomed

Completed

Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy
Depomed

Completed

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

Neuralgia, Postherpetic

United States
Depomed

Completed

Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica

Healthy
Depomed

Completed

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women (Breeze3)

Hot Flashes

United States
Depomed

Completed

Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl

Healthy
Depomed

Completed

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Pain

United States
Depomed

Completed

Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

Post Herpetic Neuralgia

United States
Depomed

Completed

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.

Hot Flashes

United States
Depomed

Completed

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Hot Flashes

United States
Grünenthal GmbH
Depomed

Completed

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Acute Pain

United States, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Poland, Spain, United Kingdom
Grünenthal GmbH
Depomed

Terminated

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Moderate to Severe Acute Postoperative Pain

United States, United Kingdom, Poland
Scripps Health
Depomed

Unknown

IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine

Migraine Headache

United States
M.D. Anderson Cancer Center
Depomed

Completed

Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
The Center for Clinical Research, Winston-Salem...
Depomed

Completed

Study of Gralise to Treat Fibromyalgia Patients (Gralise)

Fibromyalgia

United States
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM313 in Healthy Subjects

Healthy
Keymed Biosciences Co.Ltd

Not yet recruiting

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd

Not yet recruiting

Multiple Ascending Dose Study of CM338 in Healthy Volunteers

Healthy Subjects
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM350 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma

Lymphoma | Multiple Myeloma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (DUBHE)

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Single Dose Escalation Study of CM383 in Healthy Volunteers

Alzheimer Disease
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
Keymed Biosciences Co.Ltd

Recruiting

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

IgA Nephropathy

China
Keymed Biosciences Co.Ltd

Recruiting

Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

Healthy

China
Keymed Biosciences Co.Ltd

Recruiting

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Gastric Cancer | Pancreatic Cancer | Advanced Solid Tumor | Gastroesophageal Junction Adenocarcinoma

China
Keymed Biosciences Co.Ltd

Completed

A Study of CM310 in Subjects With Moderate to Severe Asthma

Asthma

China
Keymed Biosciences Co.Ltd

Active, not recruiting

Study of CM310 in Subjects With Allergic Rhinitis (PHECDA)

Allergic Rhinitis

China
Keymed Biosciences Co.Ltd

Completed

Study of CM310 in Healthy Subjects

Healthy

China
Keymed Biosciences Co.Ltd

Completed

A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

Asthma

China
Keymed Biosciences Co.Ltd

Completed

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Chronic Rhinosinusitis (Diagnosis) | Nasal Polyps

China
Keymed Biosciences Co.Ltd

Completed

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Moderate-to-severe Atopic Dermatitis

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Prurigo Nodularis
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Chronic Rhinosinusitis With Nasal Polyps

China
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Atopic Dermatitis

China

3

Subscribe